Medical Journal April 2025 Digital Edition
Post Views: 1,429
BY Blinn E. Combs, Esq. and Michael R. Alexander, Esq., Brown & Fortunato, P.C. On April 1, Robert F. Kennedy, Jr., newly installed Secretary of the federal Health and Human Services Department (“HHS”) began implementing changes announced on March 27 as part of the Trump Administration’s Make America Healthy Again initiative. The press release and related fact sheet promised large-scale restructuring of the HHS and the many departments operating under it. Released plans included...
BY Hunter Sundbeck, Manager, Consulting Services, Weaver Perspectives on the most critical aspects of the health care supply chain vary significantly depending on one’s role within the health care ecosystem. A hospital nurse may prioritize the secure transportation of medicinal products, while a hospital administrator might consider daily operational equipment more vital. Meanwhile, a regional clinic may continue using a seven-year-old blood pressure monitor, inadvertently introducing cyber vulnerabilities that could render the device inoperable...
BY Samuel Mathis MD, MBA One of my favorite scents is lavender. It is a perfect fragrance of floral notes with a mix of herbal and woody scents combined. Smelling it always puts me at ease. While lavender is typically touted for its scent and used in soaps, candles, lotions, and diffusers, it actually has some wonderful health benefits as well. A colleague recently sent me an article about the effects of lavender on...
By: John Hawkins, President and CEO, THA There is nothing more central to the mission of a hospital than saving lives. If you want our Texas Hospital Association to throw our support behind a bill, the quickest route to opening that discussion is to tell us that the bill will save lives and then show us how. Saving lives is the very reason THA is supporting one of the most consequential – and...
Memorial Hermann Health System proudly announces that Lori Knowles, Senior Vice President and Chief Human Resources Officer, has been named to Becker’s Hospital Review’s list of ‘Hospital and Health System CHROs and Chief People Officers to Know’ for the second consecutive year. This recognition acknowledges leading human resources executives for their pivotal role in developing and executing human capital strategies essential to the success of their hospitals and health systems. A key advocate for employee-centric...
Memorial Hermann Health System proudly announces that Amalia Maislos Stanton, Senior Vice President and Chief Strategic Communications and Marketing Officer, has been named to Becker’s Hospital Review’s 2024 list of ‘Hospital and Health System Chief Marketing Officers to Know.’ According to Becker’s, this recognition honors strategic leaders who influence how their organizations are perceived and experienced through brand building, data-driven campaigns and strong customer relationship strategies. In her role, Stanton is responsible for elevating brand...
The University of Texas MD Anderson Cancer Center broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services and MD Anderson’s unparalleled patient experience closer to those living in Southwest Houston and the surrounding areas. Anticipated to open in 2029, the five-story location will be MD Anderson’s largest Houston-area location to date. The facility will broaden services available at MD Anderson’s current Sugar Land location to include a new ambulatory surgery center, as well...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates for patients with refractory CD30-positive lymphomas. Results from the Phase I trial demonstrated an overall response rate of 92.9% and a complete response of 66.7% in 42 heavily pretreated patients. These findings suggest this unique cell therapy approach has promise for specific patients with lymphoma, but it may...
New research out of the University of Texas Medical Branch reveals findings that drug candidate NITD-688 utilized a unique way to stop dengue, a potentially life-threatening infection spread by mosquitos. Dengue, caused by the dengue virus, presents a significant public health challenge with limited effective treatments. Primarily transmitted to humans through the bite of infected mosquitoes, the virus can cause diseases ranging from mild flu-like illness to life-threatening dengue hemorrhagic fever and dengue shock syndrome....